Vanguard Total Stock Market ETF (VTI)
294.00
+0.00 (0.00%)
NYSE · Last Trade: Jun 18th, 9:14 AM EDT
G7 leaders unveiled an action plan to ensure global supplies of critical minerals for clean energy, defense, and digital technology. Partnerships with developing countries and investment in sustainable production are key.
Via Benzinga · June 18, 2025
Trump met with Canadian PM Carney to discuss strained relations at G7 summit. Talks were optimistic and a deal is possible within weeks.
Via Benzinga · June 18, 2025
The stock’s previous intraday high was $208.39, reached on Feb. 19, while its all-time closing high of $208.28 came a session earlier.
Via Stocktwits · June 18, 2025
The lawmakers quoted media reports that said Palantir employees installed at the IRS were helping the agency use the company’s software to create a “single, searchable database” of taxpayers’ records.
Via Stocktwits · June 18, 2025
CEO Andy Jassy said the company wants to expedite its GenAI plunge due to its “strong conviction” that AI agents will change the future.
Via Stocktwits · June 18, 2025
Turner will take over on Oct. 1, replacing David Gibbs, who had announced he would retire by the end of the year.
Via Stocktwits · June 18, 2025
Earlier this week, Amazon announced a similar deal with Roku, with the integration aimed at giving advertisers access to 80 million U.S. ConnectedTV households in the U.S. exclusively through Amazon DSP.
Via Stocktwits · June 18, 2025
The struggling chipmaker is planning reductions of up to 15% to 20% at its factory division, called the Intel Foundry.
Via Stocktwits · June 18, 2025
According to the OpenAI chief, the loyalty toward OpenAI may have been due to the belief that the startup got a “really good shot,” or a much better shot at delivering super intelligence, eventually making the company more valuable.
Via Stocktwits · June 17, 2025
Chairman of the Independent Committee, Brent Turner, said the best path forward for Surgery Partners is to continue operating as an independent publicly traded company.
Via Stocktwits · June 17, 2025
Lilly will acquire all outstanding shares of Verve for $10.50 per share in cash payable at closing, in addition to a contingent value right (CVR) per share that entitles holders to $3 per share, subject to the completion of certain milestones.
Via Stocktwits · June 17, 2025
Wells now expects Tesla to report full-year deliveries down 21% year-over-year.
Via Stocktwits · June 17, 2025
The housing market continues to be in flux due to high mortgage rates, recession fears, and growing uncertainty tied to U.S. tariff policies.
Via Stocktwits · June 17, 2025
Analysts at Deutsche Bank expect the Incremental growth in higher-margin revenues and the breadth of its supply chain to help "deftly navigate" incremental tariffs and reinvest in growth.
Via Stocktwits · June 17, 2025
Jonah Cheng’s liquidation followed fears about delays in GB200 racks, inventory risks, a lack of upward revisions to earnings forecasts, competition from custom-designed chips, and uncertainty around spending by cloud computing companies.
Via Stocktwits · June 17, 2025
Morgan Stanley’s James Faucette expects the company to raise the bottom end of its 2025 revenue guidance by 100 basis points, layering in longer-duration managed services contracts.
Via Stocktwits · June 17, 2025
The National Labor Relations Board has written to the e-commerce giant to reinstate fired workers and ensure union supporters receive the raises, bonuses, and promotions.
Via Stocktwits · June 17, 2025
One of the potential buyers for Coty's luxury business is perfume maker Interparfums, although talks are at an early stage.
Via Stocktwits · June 16, 2025
Microsoft enhanced its European cloud offerings with advanced data control, sovereignty, and privacy tools, ensuring local data processing, stricter access oversight, and customer-managed encryption.
Via Stocktwits · June 16, 2025
The new price target of $118 represents an upside of over 18% from the stock’s closing price of $99.74 on Friday.
Via Stocktwits · June 16, 2025
The analyst highlighted the company’s improved sales, innovative products, strategic marketing, and the acquisition of Alani Nu.
Via Stocktwits · June 16, 2025
The newly announced partnership aims to develop SIM0505, a novel antibody-drug conjugate developed by Simcere Zaiming for the treatment of solid tumors.
Via Stocktwits · June 16, 2025
The company stated that no safety signals were observed in the study comparing the efficacy and safety of Venetoclax in combination with Azacitidine compared to Azacitidine and placebo in the treatment of newly diagnosed, higher-risk MDS.
Via Stocktwits · June 16, 2025
Sonim’s Special Committee, tasked with overseeing strategic alternatives, acknowledged the proposal but noted that it lacks the information needed to properly assess the offer.
Via Stocktwits · June 16, 2025
Piper Sandler cut its Elevidys peak sales estimate to $1.7 billion from $2.4 billion.
Via Stocktwits · June 16, 2025